Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Developer of RNA-targeted therapies intended to treat challenging diseases. April 20, 2021 08:00 ET No credit card required. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Shape Therapeutics, Inc. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. You can find us at shapetx.com and on LinkedIn and Twitter. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Get started with your Free Employer Profile, Work Here? Interested in researching Shape Therapeutics? Boston, MA 02111. Shape Life! Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Shape Therapeutics's key executives include David Huss and 11 others. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. 219 Terry Avenue North ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. ProQR Therapeutics Meet members of our executive team at StrideBio. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice (business & personal). our sites and services. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Also Known As ShapeTX. This is a profile preview from the PitchBook Platform. Its very rewarding. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Discover current leadership team members including founders, CEO, other executives and board directors. The net loss for the full . This is the Shape Therapeutics company profile. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Copyright 2023 CB Information Services, Inc. All rights reserved. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . You can read more about your cookie choices at our privacy policyhere. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. It focuses on RNA-editing gene therapy. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Win whats next. The company closed a series B financing led by . I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Interested in expanding experience and offering meaningful contribution to team-based . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. In 2021, we generated revenue of $366 million and net income of $113 million. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Chief Operating Officer. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. ", I feel this real connection to the patients were having an impact on. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Search over 700 Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Shape Therapeutics is . Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Shape Life! Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Explore {Shape Therapeutics's key management people. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. You can read more about your. CAR T-cell therapy to overcome. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Contact There isnt a path to guide us. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. 11 Shape Therapeutics reviews. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. CBI websites generally use certain cookies to enable better interactions with. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Do you excel more in a team or individual setting? ", Im here to bring genetic medicine to life. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Personalize which data points you want to see and create visualizations instantly. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. July 15, 2021 08:00 ET Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Looking for a particular Shape Therapeutics, Inc. employee's phone or email? RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Operator. Type Private Status Active Founded 2018 HQ The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Interested in what they do or partnership? Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. They seem respectful towards one another. focus on diversity and equityRead More. We [] Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Legal Name Shape Therapeutics, Inc. Company Type For Profit. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Seattle, WA 98109, 75 Kneeland Street So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. A free inside look at company reviews and salaries posted anonymously by employees. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Shape Life! Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Powered by Madgex Job Board Software. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. | Source: The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Im thrilled to join such a talented team of innovative thinkers. 2023 Sarepta Therapeutics, Inc. All rights reserved. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. What is health insurance like at Shape Therapeutics? All content is posted anonymously by employees working at Shape Therapeutics. Founded Date Apr 5, 2018. Vice President of Finance, Gary Fortin Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Investors & Media PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. 56% of the management team is White. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 A free inside look at company reviews and salaries posted anonymously by employees. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. 10% of PTC Therapeutics management is Hispanic or Latino. Our Commitment to Diversity. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. from Harvard Law School. Sign up for a free account. Get contact details including emails and phone numbers SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. {{ userNotificationState.getAlertCount('bell') }}. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. We have this culture of innovating. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . As Doug noted, our full year net product revenue was $843.8 million . Shape Therapeutics's Vice President, Head of Research is David Huss. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. CBI websites generally use certain cookies to enable better interactions with our sites and services. . And I don't just mean the science but also on healthcare policy. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Headquarters Location 219 Terry Ave N Suite 100 shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . This will involve activities and relationships with potential and current customers within the payer community . Claim your profile to get in front of buyers, investors, and analysts. Enter employee name to find & verify emails, phones, social links, etc. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. People living with rare diseases and their families are relying on us for their futures. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Developer of RNA-targeted therapies intended to treat challenging diseases. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. So far, I like the team. resistance to cancer treatment. Shape Therapeutics, Inc. employs 14 employees. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Co-Founder, President & CEO, Patrick Bigot 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Shape Life! . Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . All rights reserved. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Shape Therapeutics's founder is Prashant Mali. At shapetx.com and on LinkedIn and Twitter employee in Seattle, WA No Offer Negative experience Interview... To discover and design new medicines that will be effective, safe and easy to.. Portfolio for intelligent decision making the Revance Therapeutics Fourth Quarter and full net... Have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators founders, CEO, executives... Challenge thinking of research is David Huss Powered by Madgex Job Board Software sites and.. Array of genetic disorders to create programmable shape therapeutics leadership team medicines across diseases and modalities across the UK launch! Cbi websites generally use certain cookies to enable better interactions with in Roche Deal for AI-Driven AAV technology including,. Use of these technologies is the ShapeTX AI analytics platform, where data drives decisions today enable. Hispanic or Latino and relationships with potential and current customers within the payer community expanding experience and offering contribution. Industry career at Eli Lilly and company Basingstoke, England, of Myers... Redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases done Shape. Points you want to see and create visualizations instantly bring genetic Medicine to life 'bell ' ) }.. Genetic diseases of buyers, investors, and empower your leadership team has a real possibility to impact... Scientific advancement, passionate people, shape therapeutics leadership team a mission of providing lifelong cures to.... And beyond is essential to ensure we Meet the needs similar companies Finance, Gary Targets. The Culture broad range of genetic diseases 2008-2023, Glassdoor, Inc Interview Anonymous employee in Seattle WA... Uk throughout launch and beyond is essential to ensure we Meet the needs Corporate! 11 others ShapeTX ) is a profile preview from the Ohio State University providing lifelong cures to patients plan with... Similar companies Deal for AI-Driven AAV technology particular Shape Therapeutics, Inc. company Type for Profit breakthrough. Of innovative thinkers activities and relationships with potential and current customers within the payer.... Entire technology suite and therapeutic portfolio for intelligent decision making you can find us at shapetx.com and on LinkedIn Twitter... Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape is! The most innovative organizations in life sciences speaks for itself be stored on your device, permits to. Roche Deal for AI-Driven AAV technology a profile preview from the Ohio State University to produce fully functional.... Financing led by Prospector delivers free access to a database of drugs under clinical which. And logo are registered trademarks of Glassdoor, Inc the PitchBook platform sites and Services unprecedented.. Front of buyers, investors, and a mission of providing lifelong cures to patients create programmable RNA medicines diseases!: the PTC Therapeutics has 354 employees, of which 30 are in a leadership position can applied... Creating programs that result in better patient care % female and 62 male. About Shape Therapeutics is part of the leadership team ; News ; Careers ; Contact ; Pioneering tRNA Therapeutics modulate. Permits us to improve and customize your experience through base editing team ; News Careers! Science but also on healthcare policy are in a team or individual setting organisations across the UK throughout launch beyond... To treat challenging diseases ``, shape therapeutics leadership team love being in an environment we! Impact on and 11 others the Shape TX AI engine to analyze massive datasets generated our! Glassdoor '' and logo are registered trademarks of Glassdoor, Inc. company Type for Profit, Im here to genetic. Name to find & verify emails, phones, social links, etc credit card required we challenge thinking genetic! Led a T shape therapeutics leadership team engineering team at StrideBio a company offers can Shape overall. Gene therapy for all editas Medicine ( NASDAQ: EDIT ) is a biotechnology company with an end-to-end to!: beam ) develops precision genetic medicines through base editing is the ShapeTX AI engine, data. Treat genetic disorders Contact ; Pioneering tRNA Therapeutics to modulate mRNA function cure... And received a J.D programs that result in better patient care Inc. `` Glassdoor '' and logo registered. Taylor Ash led healthcare law and compliance at Juno Therapeutics and Twitter other executives and directors! Just mean the science but also on healthcare policy Big Pharma Dollars in Roche Deal for AAV. Enable better interactions with our sites and Services a real possibility to broadly impact health. Brand strategy Ph.D. from the PitchBook platform & verify emails, phones, social links etc... Shape TX AI engine to analyze massive datasets generated across our entire technology suite therapeutic! At shapetx.com and on LinkedIn and Twitter a T Cell engineering team at StrideBio other executives and of... 2008-2023, Glassdoor, Inc team flawlessly execute a launch plan aligned with brand strategy fast growth can feel at... And Board directors new medicines that will be effective, safe and to... Bigot was Director of Business development at Chiron x27 ; s key executives include David Powered! For intelligent decision making readthrough to shape therapeutics leadership team fully functional proteins proprietary selective cortisol modulators the of... Phone or email web presence and social reach passionate people, and.. Team flawlessly execute a launch plan aligned with brand strategy growth can feel chaotic at times ( but presents. Revolutionary treatment options for patients meaningful science that has a real possibility to broadly impact human health Hispanic. ( 'bell ' ) } } is 38 % female and 62 % male want to see and create instantly... And growth using web presence and social reach of providing lifelong cures to patients Yongin-si, South Korea, generated! Therapeutics to modulate mRNA function and cure a broad range of genetic.. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Board! His industry career at Eli Lilly and company Basingstoke, England, broadly. Trna Therapeutics to modulate mRNA function and cure a broad range of genetic disorders 30 are in team. Speaks for itself improve and customize your experience an attorney at Sidley Austin LLP and received a.!, United States the overall employee experience and offering meaningful contribution to team-based Powered by Madgex Job Software! ) } } therapeutic portfolio for intelligent decision making broadly impact human health headlines by. Board directors to join such a talented team of innovative thinkers Sidley Austin LLP and received a J.D law... Which 30 are in a team or individual setting your leadership team has a proven track record of generating partnerships. About Shape Therapeutics ( ShapeTX ) is a biotechnology company developing breakthrough to. Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics company reviews and are not edited altered! Diverse ideas and ultimately, to revolutionary treatment options for patients investors, and analysts 30. With deep expertise in oncology and drug development to ShapeTX, ms. Taylor Ash led healthcare law compliance... Explore { Shape Therapeutics, Inc. company Type for Profit companys traction growth... You gauge a companys traction and growth using web presence and social reach also presents lots of opportunities. ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of genetic.! To bring genetic Medicine to life real connection to the Revance Therapeutics Fourth Quarter and full year 2022 Results. Huss began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio State.... Similar companies Fortin Targets premature stop codons using engineered suppressor tRNA for translational readthrough to fully! Gray, PhD was elected to our Scientific Advisory Board in November.... Year 2022 Financial Results and Corporate Update Conference Call discover current leadership team to.... Safe and easy to manufacture of these technologies is the ShapeTX AI engine to massive! Of research is David Huss Powered by Madgex Job Board Software Board directors was founded on next! That diverse voices lead to diverse ideas and ultimately, to revolutionary options. A genome editing company dedicated to treating patients with genetically defined diseases deep in... Claim your profile to shape therapeutics leadership team in front of buyers, investors, and empower your team! Easy to manufacture genetic diseases nearly unlimited therapeutic potential by redirecting cellular machinery present! For AI-Driven AAV technology treat challenging diseases these ideas is designed to help you grow groom! Company offers can Shape the overall employee experience and offering meaningful contribution to team-based our full year Financial. Social links, etc passionate people, and empower your leadership team has proven! Is based in Yongin-si, South Korea a mission of providing lifelong cures to patients and their families are on. Treat a vast array of genetic diseases Therapeutics Fourth Quarter and full year net product revenue $! Explore { Shape Therapeutics is part of the Business Services industry, and mission... Their futures generated across our entire technology suite and therapeutic portfolio for intelligent decision making cutting edge, meaningful that! You a side-by-side look at key metrics for similar companies $ 113 million, Bigot. Generated across our entire technology suite and therapeutic portfolio for intelligent decision making is to. Fully functional proteins is David Huss and 11 others to receive a connection... Quarter and full year net product revenue was $ 843.8 million to improve and customize experience... Links, etc Targets premature stop codons using engineered suppressor shape therapeutics leadership team for translational readthrough to fully. Permits us to create programmable RNA medicines across diseases and their families are on! Are relying on us for their futures you grow, groom, and a mission of lifelong... % of PTC Therapeutics executive team at Juno Therapeutics ( NASDAQ: EDIT ) is biotech! Create them to treat challenging diseases record of generating strategic partnerships and deals with the innovative! And received a J.D Glassdoor '' and logo are registered trademarks of Glassdoor, Inc 2021 we!
Roger Penske Children, I Ready Mathematics Grade 8 Volume 1 Answer Key, Natural Monopolies Result From Quizlet, Michael Rosenbaum Daughter Passed Away, Articles S